Evidence map›Paper›PMID 39012947›Full record

ArticleCirculation. Cardiovascular imaging2024

Elevated Lipoprotein(a) With Zero Coronary Artery Calcium: A Silent Threat or a Clinical Paradox?

Patricia F Rodriguez Lozano, Nisha Hosadurg

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Cardiovascular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Sex-specific influence of Lipoprotein(a) levels on coronary plaque characteristics: - The COPRODUCTION Registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Patricia F Rodriguez LozanoDepartment of Medicine, Cardiovascular Division (P.F.R.L., N.H.), University of Virginia Health, Charlottesville.ORCID 0000-0003-1888-8899
Nisha HosadurgDepartment of Medicine, Cardiovascular Division (P.F.R.L., N.H.), University of Virginia Health, Charlottesville.

Funding

The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve HealthUL1TR003015 · NCATS · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, JOHNSTON, KAREN C. · 2019 to 2023
$20.3M
Training in Cardiovascular Imaging ResearchT32EB003841 · NIBIB · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jonathan R Lindner · 2004 to 2026
$4.4M
Institutional Career Development CoreKL2TR003016 · NCATS · UNIVERSITY OF VIRGINIA · PI PAPIN, JASON, WORRALL, BRADFORD B · 2019 to 2023
$3.9M
Innovative Therapy to Treat Women with Angina with Nonobstructive CAD (ANOCA) and Coronary Microvascular DiseaseK01HL174889 · NHLBI · UNIVERSITY OF VIRGINIA · PI Patricia Fiorella Rodriguez Lozano · 2024 to 2026
$486k
NCATS NIH HHS KL2 TR003016NCATS NIH HHS UL1 TR003015NHLBI NIH HHS K01 HL174889NIBIB NIH HHS T32 EB003841
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersCoronary Artery DiseaseLipoprotein(a)Vascular CalcificationComputed Tomography AngiographyCoronary AngiographyCoronary VesselsHumansMalePredictive Value of TestsBiomarkersLipoprotein(a)LPA protein, humanangiographycardiovascular diseasesEditorialslipoproteinrisk factors

Identifiers

PMID39012947
PMCPMC12404233

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.